data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Trevena
(NASDAQ:TRVN)
$0.3901
0.0001[0.03%]
At close: Jul 5
$0.4094
0.0193[4.95%]
After Hours: 9:06AM EDT
Day High/Low0.38 - 0.41
52 Week High/Low0.18 - 1.81
Open / Close0.38 / 0.39
Float / Outstanding163.9M / 165.5M
Vol / Avg.810.4K / 2.1M
Mkt Cap64.6M
P/E-
50d Avg. Price0.33
Div / Yield-
Payout Ratio-
EPS-0.1
Total Float163.9M

Trevena (NASDAQ:TRVN), Quotes and News Summary

Trevena (NASDAQ: TRVN)

Day High/Low0.38 - 0.41
52 Week High/Low0.18 - 1.81
Open / Close0.38 / 0.39
Float / Outstanding163.9M / 165.5M
Vol / Avg.810.4K / 2.1M
Mkt Cap64.6M
P/E-
50d Avg. Price0.33
Div / Yield-
Payout Ratio-
EPS-0.1
Total Float163.9M
Benzinga - May 27, 2022, 3:41AM
Benzinga - May 12, 2022, 11:11AM
Benzinga - May 11, 2022, 7:16AM
Benzinga - Apr 25, 2022, 7:12AM
Benzinga - Apr 20, 2022, 7:10AM
Benzinga - Mar 31, 2022, 10:39AM
Benzinga - Mar 31, 2022, 7:06AM
Benzinga - Mar 31, 2022, 7:05AM
Sector: Health Care.Industry: Biotechnology
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.100
REV20.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Trevena Questions & Answers

Q
How do I buy Trevena (TRVN) stock?
A

You can purchase shares of Trevena (NASDAQ: TRVN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Trevena's (TRVN) competitors?
Q
What is the target price for Trevena (TRVN) stock?
A

The latest price target for Trevena (NASDAQ: TRVN) was reported by HC Wainwright & Co. on Thursday, May 12, 2022. The analyst firm set a price target for 3.50 expecting TRVN to rise to within 12 months (a possible 797.21% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Trevena (TRVN)?
A

The stock price for Trevena (NASDAQ: TRVN) is $0.3901 last updated July 5, 2022, 8:00 PM UTC.

Q
Does Trevena (TRVN) pay a dividend?
A

There are no upcoming dividends for Trevena.

Q
When is Trevena (NASDAQ:TRVN) reporting earnings?
A

Trevena’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Trevena (TRVN) going to split?
A

There is no upcoming split for Trevena.

Q
What sector and industry does Trevena (TRVN) operate in?
A

Trevena is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.